CARDIOMYOPATHY
Clinical trials for CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart MRI showdown: which contrast agent is best?
Diagnosis CompletedThis study looked at 120 people with heart disease who needed a heart MRI. It compared two contrast agents, Dotarem and Gadovist, to see if they produce equally clear images. The goal was to find out if both agents work well for detecting heart damage and predicting future heart …
Matched conditions: CARDIOMYOPATHY
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Diagnosis
Last updated Jun 15, 2026 19:07 UTC
-
Heart drug fails to shield duchenne boys from cardiac decline
Prevention CompletedThis study tested whether nebivolol, a beta-blocker heart drug, could prevent heart failure in 51 boys aged 10-15 with Duchenne muscular dystrophy. Participants had normal heart function at the start and were randomly given either nebivolol or a placebo. The trial found that nebi…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 05, 2026 12:08 UTC
-
AI-Powered phone ECG could spot hidden heart disease in families
Knowledge-focused CompletedThis study tested whether a mobile ECG device, combined with artificial intelligence, can help screen close relatives of people with dilated cardiomyopathy (a weakened heart muscle). 119 participants used a handheld device to record their heart's electrical activity, which was th…
Matched conditions: CARDIOMYOPATHY
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 16, 2026 22:21 UTC
-
Healthy volunteers test new heart Drug's absorption
Knowledge-focused CompletedThis study looked at how the body absorbs a new drug called HRS-1893, which is being developed for heart muscle disease (cardiomyopathy). 38 healthy adults took different versions of the tablet, with and without food, to see which form works best and if food changes how much drug…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:55 UTC
-
Heart failure mystery solved? Beta-Blockers boost pumping power
Knowledge-focused CompletedThis study looked at how beta-blocker medicines improve heart function in 55 adults with heart failure and weak heart muscles. Researchers measured changes in the heart's ability to contract and pump blood. The goal was to understand the mechanism behind the improvement, not to t…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE4 • Sponsor: Michael E. DeBakey VA Medical Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC
-
Gene study seeks clues to inflammation and disease risk
Knowledge-focused CompletedThis study looked at how certain genes in blood cells respond to environmental exposures in 178 healthy volunteers aged 18 to 45. Researchers measured gene activity to better understand links to inflammation, cancer, and other diseases. The goal was to gather knowledge, not to pr…
Matched conditions: CARDIOMYOPATHY
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:07 UTC